$BOSC
BOS BETTER ONLINE SOLUTIONS LTD Stock $bosc

$bosc Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 20-F Financial Statement

#000121390024028176 Filed on April 01, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue		$10.89M	$44.18M
YoY Change		-3.9%	6.43%
Cost Of Revenue		$8.796M	$34.97M
YoY Change		0.66%	7.76%
Gross Profit		$2.090M	$9.209M
YoY Change		-19.31%	1.64%
Gross Profit Margin		19.2%	20.84%
Selling, General & Admin		$1.698M	$6.653M
YoY Change		-12.43%	-5.58%
% of Gross Profit		81.24%	72.24%
Research & Development		$44.00K	$158.0K
YoY Change		15.79%	-4.82%
% of Gross Profit		2.11%	1.72%
Depreciation & Amortization			$510.0K
YoY Change			100.79%
% of Gross Profit			5.54%
Operating Expenses		$1.690M	$6.759M
YoY Change		-14.52%	-6.28%
Operating Profit		$400.0K	$2.450M
YoY Change		-34.75%	27.01%
Interest Expense		$31.00K	-$441.0K
YoY Change		-126.96%
% of Operating Profit		7.75%	-18.0%
Other Income/Expense, Net			-$441.0K
YoY Change			-31.84%
Pretax Income		$431.0K	$2.009M
YoY Change		-19.74%	56.71%
Income Tax		$4.000K	$4.000K
% Of Pretax Income		0.93%	0.2%
Net Earnings		$427.0K	$2.005M
YoY Change		-19.59%	57.13%
Net Earnings / Revenue		3.92%	4.54%
Basic Earnings Per Share			$0.35
Diluted Earnings Per Share		$0.07	$0.34
COMMON SHARES
Basic Shares Outstanding	5.748M shares		5.727M shares
Diluted Shares Outstanding			5.905M shares

Balance Sheet

Concept	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments	$2.344M	$2.344M
YoY Change	32.96%	32.96%
Cash & Equivalents	$2.344M	$2.344M
Short-Term Investments
Other Short-Term Assets	$217.0K	$217.0K
YoY Change	114.85%	-62.06%
Inventory	$6.070M	$6.070M
Prepaid Expenses	$417.0K
Receivables	$12.42M	$12.42M
Other Receivables	$963.0K	$963.0K
Total Short-Term Assets	$22.02M	$22.02M
YoY Change	7.02%	7.02%
LONG-TERM ASSETS
Property, Plant & Equipment	$4.294M	$4.294M
YoY Change	-1.96%	-1.96%
Goodwill	$4.895M
YoY Change	0.0%
Intangibles	$1.078M
YoY Change	121.81%
Long-Term Investments
YoY Change
Other Assets	$196.0K	$196.0K
YoY Change	232.2%	-24.62%
Total Long-Term Assets	$10.46M	$10.46M
YoY Change	4.41%	4.41%
TOTAL ASSETS
Total Short-Term Assets	$22.02M	$22.02M
Total Long-Term Assets	$10.46M	$10.46M
Total Assets	$32.48M	$32.48M
YoY Change	6.16%	6.16%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$7.710M	$7.710M
YoY Change	-3.43%	-3.43%
Accrued Expenses	$2.287M	$2.287M
YoY Change	218.08%	27.98%
Deferred Revenue	$600.0K
YoY Change	10.7%
Short-Term Debt
YoY Change
Long-Term Debt Due	$170.0K	$170.0K
YoY Change	-70.99%	-70.99%
Total Short-Term Liabilities	$10.90M	$10.90M
YoY Change	-2.6%	-2.6%
LONG-TERM LIABILITIES
Long-Term Debt	$1.150M	$1.150M
YoY Change	-11.13%	-11.13%
Other Long-Term Liabilities	$1.588M	$1.588M
YoY Change	7.88%	7.88%
Total Long-Term Liabilities	$2.738M	$2.738M
YoY Change	-1.01%	-1.01%
TOTAL LIABILITIES
Total Short-Term Liabilities	$10.90M	$10.90M
Total Long-Term Liabilities	$2.738M	$2.738M
Total Liabilities	$13.64M	$13.64M
YoY Change	-2.28%	-2.28%
SHAREHOLDERS EQUITY
Retained Earnings	-$67.13M
YoY Change	-2.9%
Common Stock	$86.21M
YoY Change	0.23%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$18.84M	$18.84M
YoY Change
Total Liabilities & Shareholders Equity	$32.48M	$32.48M
YoY Change	6.16%	6.16%

Cashflow Statement

Concept	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	$427.0K	$2.005M
YoY Change	-19.59%	57.13%
Depreciation, Depletion And Amortization		$510.0K
YoY Change		100.79%
Cash From Operating Activities		$1.829M
YoY Change		42.56%
INVESTING ACTIVITIES
Capital Expenditures		$772.0K
YoY Change		-68.19%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities		-$772.0K
YoY Change		-75.02%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$102.0K
YoY Change		-88.82%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		-389.0K
YoY Change		-124.56%
NET CHANGE
Cash From Operating Activities		1.829M
Cash From Investing Activities		-772.0K
Cash From Financing Activities		-389.0K
Net Change In Cash		668.0K
YoY Change		-398.21%
FREE CASH FLOW
Cash From Operating Activities		$1.829M
Capital Expenditures		$772.0K
Free Cash Flow		$1.057M
YoY Change		-192.4%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-14184
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	20 Freiman Street
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Rishon LeZion
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	7535825
CY2023	dei	Entity Address Country EntityAddressCountry	IL
CY2023	dei	Security12b Title Security12bTitle	Ordinary Shares, of no nominal value per share
CY2023	dei	Trading Symbol TradingSymbol	BOSC
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5748018	shares
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Firm AuditorFirmId	1375
CY2023	dei	Auditor Name AuditorName	FAHN KANNE & CO.
CY2023	dei	Auditor Location AuditorLocation	Tel-Aviv, Israel
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2344000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1763000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	217000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	130000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	287000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	82000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	12424000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	10834000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	963000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1414000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	6070000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6433000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	22018000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	20574000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	196000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	260000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3268000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3270000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1026000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1110000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1078000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	486000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	4895000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	4895000	usd
CY2023Q4	us-gaap	Assets Assets	32481000	usd
CY2022Q4	us-gaap	Assets Assets	30595000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	170000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	586000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	235000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	301000	usd
CY2023Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	7710000	usd
CY2022Q4	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	7984000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	980000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1016000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	600000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	542000	usd
CY2023Q4	bosc	Advances Net Of Inventory In Progress AdvancesNetOfInventoryInProgress	137000	usd
CY2022Q4	bosc	Advances Net Of Inventory In Progress AdvancesNetOfInventoryInProgress	47000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1072000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	719000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10904000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	11195000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1150000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1294000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	759000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	827000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	339000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	241000	usd
CY2023Q4	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	490000	usd
CY2022Q4	us-gaap	Postemployment Benefits Liability Noncurrent PostemploymentBenefitsLiabilityNoncurrent	404000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2738000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	2766000	usd
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	11000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	11000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5748018	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5748018	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5701518	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5701518	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	86209000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	86009000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-243000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-243000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-67127000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-69132000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	18839000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	16634000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	32481000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30595000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	44179000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	41511000	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	33634000	usd
CY2023	us-gaap	Cost Of Revenue CostOfRevenue	34970000	usd
CY2022	us-gaap	Cost Of Revenue CostOfRevenue	32451000	usd
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	27048000	usd
CY2023	us-gaap	Gross Profit GrossProfit	9209000	usd
CY2022	us-gaap	Gross Profit GrossProfit	9060000	usd
CY2021	us-gaap	Gross Profit GrossProfit	6586000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	158000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	166000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	208000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4891000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	4924000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3955000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1762000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2122000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1906000	usd
CY2023	us-gaap	Other Income OtherIncome	52000	usd
CY2022	us-gaap	Other Income OtherIncome	81000	usd
CY2023	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	6759000	usd
CY2022	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	7131000	usd
CY2021	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	6069000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	2450000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	1929000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	517000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-441000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-647000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-105000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2009000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1282000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	412000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-39000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2005000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1276000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	451000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.35
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.23
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.34
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5727000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5550000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5212000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5905000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5589000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5424000	shares
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	11869000	usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	94000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	119000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1814000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	451000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	14347000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	97000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	2000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	912000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1276000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	16634000	usd
CY2023	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	97000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	103000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2005000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	18839000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2005000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1276000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	451000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	510000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	361000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	258000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss After Tax ForeignCurrencyTransactionGainLossAfterTax	69000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss After Tax ForeignCurrencyTransactionGainLossAfterTax	211000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss After Tax ForeignCurrencyTransactionGainLossAfterTax	-39000	usd
CY2023	bosc	Severance Pay Net SeverancePayNet	-86000	usd
CY2022	bosc	Severance Pay Net SeverancePayNet	-124000	usd
CY2021	bosc	Severance Pay Net SeverancePayNet	84000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	98000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	97000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	67000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1590000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1625000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	37000	usd
CY2023	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-515000	usd
CY2022	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	547000	usd
CY2021	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-243000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-453000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1068000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	515000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-304000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-582000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-491000	usd
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-354000	usd
CY2022	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-723000	usd
CY2021	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-491000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-274000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	2785000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-292000	usd
CY2023	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	145000	usd
CY2022	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	232000	usd
CY2021	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-121000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1829000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1283000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	9000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	341000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	2427000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	379000	usd
CY2022	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities	664000	usd
CY2023	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets	431000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-772000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3091000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-379000	usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	912000	usd
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	1841000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	102000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	119000	usd
CY2023	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	93000	usd
CY2022	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	1356000	usd
CY2021	us-gaap	Proceeds From Issuance Of Debt ProceedsFromIssuanceOfDebt	173000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1311000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	668000	usd
CY2023	us-gaap	Repayments Of Debt RepaymentsOfDebt	584000	usd
CY2022	us-gaap	Repayments Of Debt RepaymentsOfDebt	686000	usd
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	822000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-389000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1584000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-224000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	941000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1893000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2117000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1176000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2561000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1893000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2117000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	118000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	58000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	59000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	220000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	748000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	669000	usd
CY2023	bosc	Operating Lease Liabilities OperatingLeaseLiabilities	220000	usd
CY2022	bosc	Operating Lease Liabilities OperatingLeaseLiabilities	748000	usd
CY2021	bosc	Operating Lease Liabilities OperatingLeaseLiabilities	669000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2344000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1763000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1875000	usd
CY2023Q4	us-gaap	Restricted Cash RestrictedCash	217000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	130000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	242000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2561000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1893000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	2117000	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	760000	usd
CY2023	bosc	Accrued Expenses AccruedExpenses	329000	usd
CY2023	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	431000	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	445000	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	219000	usd
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Value Of Assets Acquired1 NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1	664000	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	pure
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Use of estimates:</span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The most significant assumptions are used with respect to the impairment analysis of goodwill and other identifiable intangible assets, revenues and the net realizable value of inventory. Actual results could differ from those estimates.</span></p>
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	446000	usd
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	267000	usd
CY2022	us-gaap	Severance Costs1 SeveranceCosts1	417000	usd
CY2021	us-gaap	Severance Costs1 SeveranceCosts1	379000	usd
CY2023	us-gaap	Contract With Customer Asset Reclassified To Receivable ContractWithCustomerAssetReclassifiedToReceivable	1770000	usd
CY2022	us-gaap	Contract With Customer Asset Reclassified To Receivable ContractWithCustomerAssetReclassifiedToReceivable	917000	usd
CY2023	us-gaap	Deferred Revenue Revenue Recognized1 DeferredRevenueRevenueRecognized1	1475000	usd
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	40000	shares
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="vertical-align: top"> <td style="width: 48px"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="width: 24px"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">n.</span></td> <td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Concentrations of credit risk and allowance for doubtful accounts:</span></td></tr> </table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents, bank deposits, trade receivables, and other accounts receivable.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The trade receivables of the Company are derived from sales to customers located primarily in Israel, the Far East, Europe and America. The Company generally does not require collateral however a part of the Company’s customers outside of Israel are insured against customer nonpayment, through the Israeli Credit Insurance Company Ltd.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">In certain circumstances, the Company may require letters of credit, other collateral, additional guarantees, or advanced payments. An allowance for doubtful accounts is determined with respect to specific debts that are doubtful of collection, in order to reflect the expected credit losses on accounts receivable balances. Judgment is required in the estimation of the allowance for doubtful accounts and the Company evaluates the collectability of its accounts receivable based on a combination of factors including, among other things, the past experience with the customers, the length of time that the balance is past due using an aging schedule, the customer’s current ability to pay and its creditworthiness using all available information about the credit risk of such customer taking into consideration the current business environment. If the Company becomes aware of a customer’s inability to meet its financial obligations, a specific allowance is recorded to reduce the net receivable to the amount reasonably believed to be collectible from such customer.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Accounts receivables are written off against the allowance for uncollectible accounts when the Company determines that these amounts are to be considered as no longer collectible.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">The expenses (income) related to the allowance for doubtful accounts for the years ended December 31, 2023, 2022 and 2021 was $205, $46 and $21, respectively. </span></p>
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	205000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	46000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	21000	usd
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	462500	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1203000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.03925	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.04105	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0084	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.42	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.43	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.48	pure
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y6M
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y6M
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y6M
CY2023Q4	us-gaap	Goodwill Fair Value Disclosure GoodwillFairValueDisclosure	4900000	usd
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.5in"></td><td style="width: 0.25in; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">v.</span></td><td style="text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Reclassification</b></span></td> </tr></table><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">Certain comparative figures have been reclassified to conform to the current year presentation. Such reclassifications did not have significant impact on the Company’s equity, net income or cash flows.</span></p>
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	219000	usd
CY2022	us-gaap	Proceeds From Divestiture Of Interest In Joint Venture ProceedsFromDivestitureOfInterestInJointVenture	723000	usd
CY2022	bosc	Sale Lease Back Transactions Monthly Rental Payments SaleLeaseBackTransactionsMonthlyRentalPayments	138000	usd
CY2022	us-gaap	Asset Acquisition Consideration Transferred Contingent Consideration AssetAcquisitionConsiderationTransferredContingentConsideration	38000	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	207000	usd
CY2022Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	167000	usd
CY2023Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	324000	usd
CY2022Q4	us-gaap	Advances On Inventory Purchases AdvancesOnInventoryPurchases	704000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	417000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	442000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	15000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	101000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	963000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1414000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	229000	usd
CY2022Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	177000	usd
CY2023Q4	us-gaap	Inventory Gross InventoryGross	1301000	usd
CY2022Q4	us-gaap	Inventory Gross InventoryGross	1750000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5260000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5788000	usd
CY2023Q4	us-gaap	Contract With Customer Receivable Allowance For Credit Loss Current ContractWithCustomerReceivableAllowanceForCreditLossCurrent	720000	usd
CY2022Q4	us-gaap	Contract With Customer Receivable Allowance For Credit Loss Current ContractWithCustomerReceivableAllowanceForCreditLossCurrent	1282000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	6070000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	6433000	usd
CY2023Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	174000	usd
CY2022Q4	us-gaap	Prepaid Expense Noncurrent PrepaidExpenseNoncurrent	201000	usd
CY2023Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	22000	usd
CY2022Q4	us-gaap	Other Assets Miscellaneous Noncurrent OtherAssetsMiscellaneousNoncurrent	59000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	196000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	260000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6871000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	6530000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3603000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3260000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3268000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3270000	usd
CY2023	us-gaap	Depreciation Depreciation	343000	usd
CY2022	us-gaap	Depreciation Depreciation	254000	usd
CY2021	us-gaap	Depreciation Depreciation	238000	usd
CY2023	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	341000	usd
CY2022	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	2427000	usd
CY2021	us-gaap	Property Plant And Equipment Additions PropertyPlantAndEquipmentAdditions	379000	usd
CY2022Q3	us-gaap	Payments To Acquire Buildings PaymentsToAcquireBuildings	2144000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	2062000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	1302000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	984000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	816000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1078000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	486000	usd
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	168000	usd
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	107000	usd
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	20000	usd
CY2022	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	219000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	4895000	usd
CY2023Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	127000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	114000	usd
CY2023Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	307000	usd
CY2022Q4	us-gaap	Taxes Payable Current TaxesPayableCurrent	344000	usd
CY2023Q4	bosc	Agent Fees AgentFees	565000	usd
CY2022Q4	bosc	Agent Fees AgentFees	12000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	73000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	249000	usd
CY2023Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	1072000	usd
CY2022Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	719000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	939000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	783000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	339000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	241000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	600000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	542000	usd
CY2023	us-gaap	Revenues Revenues	44179000	usd
CY2022	us-gaap	Revenues Revenues	41511000	usd
CY2023Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0827	pure
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	1320000	usd
CY2022Q4	us-gaap	Long Term Debt LongTermDebt	1880000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	170000	usd
CY2022Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	586000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1150000	usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	1294000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	170000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	165000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	130000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	113000	usd
CY2023Q4	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	742000	usd
CY2023Q4	us-gaap	Long Term Debt LongTermDebt	1320000	usd
CY2023	us-gaap	Line Of Credit Facility Average Outstanding Amount LineOfCreditFacilityAverageOutstandingAmount	1314000	usd
CY2023	us-gaap	Line Of Credit Facility Interest Rate During Period LineOfCreditFacilityInterestRateDuringPeriod	0.0779	pure
CY2023	us-gaap	Other Commitments Description OtherCommitmentsDescription	Under the Company’s research and development agreements with the Israel Innovation Authority (the IIA) and pursuant to applicable laws, the Company is required to pay royalties at the rate of 3.5% of sales of products developed with funds provided by the IIA, up to an amount equal to 100% of the research and development grants (dollar-linked) received from the IIA.
CY2023	us-gaap	Royalty Expense RoyaltyExpense	3603000	usd
CY2022Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	500000000	ils
CY2022Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	160000000	usd
CY2022Q3	us-gaap	Loss Contingency Damages Paid Value LossContingencyDamagesPaidValue	700000000	ils
CY2022Q3	us-gaap	Loss Contingency Damages Paid Value LossContingencyDamagesPaidValue	210000000	usd
CY2022Q3	us-gaap	Proceeds From Insurance Settlement Operating Activities ProceedsFromInsuranceSettlementOperatingActivities	190000000	ils
CY2022Q3	us-gaap	Proceeds From Insurance Settlement Operating Activities ProceedsFromInsuranceSettlementOperatingActivities	54000000	usd
CY2022Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	1232709000	ils
CY2022Q1	us-gaap	Loss Contingency Damages Sought Value LossContingencyDamagesSoughtValue	361000000	usd
CY2023	us-gaap	Loss Contingency Damages Paid Value LossContingencyDamagesPaidValue	100000000	ils
CY2023	us-gaap	Loss Contingency Damages Paid Value LossContingencyDamagesPaidValue	28000000	usd
CY2019Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	400000	shares
CY2019Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	2.5
CY2019Q2	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1000000	usd
CY2019Q2	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	65000	usd
CY2019Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	240000	shares
CY2019Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	3.3
CY2023	bosc	Warrant Description WarrantDescription	The warrants were exercisable for 3.5 years and were subject to a three-year vesting period as follows: one third of the warrants shall vest annually (upon the lapse of 12 months, 24 months and 36 months from issuance), provided that on the applicable vesting date the investor did not sell any of the Ordinary Shares purchased in the private placement. Vesting of all of the warrants was to be accelerated in the event that any one or more shareholders acting together acquire a block of 40% of the Company’s issued and outstanding share capital. In addition, the Company issued 60,000 warrants as fees to a placement agent.
CY2021Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	800000	shares
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	720000	shares
CY2021Q1	us-gaap	Share Price SharePrice	2.5
CY2021Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	2000000	usd
CY2021Q1	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	1841000	usd
CY2021Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.75
CY2020Q4	bosc	Common Stock Share Authorized Increase CommonStockShareAuthorizedIncrease	2000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	6000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000	shares
CY2022Q4	bosc	Common Stock Share Authorized Increase CommonStockShareAuthorizedIncrease	3000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	8000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	11000000	shares
CY2022Q2	bosc	Ordinary Shares OrdinaryShares	450000	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Per Share Weighted Average Price Of Shares Purchased ShareBasedCompensationArrangementByShareBasedPaymentAwardPerShareWeightedAveragePriceOfSharesPurchased	2.2
CY2022Q2	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	2.2
CY2022Q2	us-gaap	Temporary Equity Stock Issued During Period Value New Issues TemporaryEquityStockIssuedDuringPeriodValueNewIssues	990000	usd
CY2022Q2	bosc	Net Issuance Expenses NetIssuanceExpenses	911000	usd
CY2022Q2	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	8100	usd
CY2023	bosc	Capital Gain Tax Rate CapitalGainTaxRate	0.25	pure
CY2023	bosc	Exercisable Annual Period ExercisableAnnualPeriod	P3Y
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Description ShareBasedCompensationArrangementByShareBasedPaymentAwardDescription	Each option granted under the Plan expires five years from the date of the grant.
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P3Y
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	98000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	97000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	67000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	0	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	70000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	26867000	usd
CY2023Q4	us-gaap	Tax Credit Carryforward Amount TaxCreditCarryforwardAmount	29775000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	6179000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	6814000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	6848000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	6848000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	240000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	176000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-128000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	-89000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	13139000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	13749000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13139000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	13749000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Not Subject To Expiration DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration	635000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	6000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2000	usd
CY2021	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit	-41000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	4000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	6000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-39000	usd
CY2021	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	-41000	usd
CY2023	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	4000	usd
CY2022	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	6000	usd
CY2021	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	2000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	4000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-39000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1990000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	1276000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	389000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	19000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	6000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	23000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2009000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1282000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	412000	usd
CY2023	us-gaap	Interest And Debt Expense InterestAndDebtExpense	402000	usd
CY2022	us-gaap	Interest And Debt Expense InterestAndDebtExpense	306000	usd
CY2021	us-gaap	Interest And Debt Expense InterestAndDebtExpense	202000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-39000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-341000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	97000	usd
CY2023	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	441000	usd
CY2022	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	647000	usd
CY2021	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	105000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-441000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-647000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-105000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2005000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1276000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	451000	usd
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2005000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1276000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	451000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5727000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5550000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	5212000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5905000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5589000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5424000	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.35
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.23
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.09
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.34
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.23
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2023	us-gaap	Revenues Revenues	44179000	usd
CY2023	us-gaap	Gross Profit GrossProfit	9209000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	6083000	usd
CY2023	us-gaap	Other Expenses OtherExpenses	676000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	2450000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-441000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2009000	usd
CY2023	us-gaap	Other Income Tax Expense Benefit Continuing Operations OtherIncomeTaxExpenseBenefitContinuingOperations	4000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	2005000	usd
CY2022	us-gaap	Revenues Revenues	41511000	usd
CY2022	us-gaap	Gross Profit GrossProfit	9060000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	6410000	usd
CY2022	us-gaap	Other Expenses OtherExpenses	721000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	1929000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-647000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	1282000	usd
CY2022	us-gaap	Other Income Tax Expense Benefit Continuing Operations OtherIncomeTaxExpenseBenefitContinuingOperations	6000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	1276000	usd
CY2021	us-gaap	Revenues Revenues	33634000	usd
CY2021	us-gaap	Gross Profit GrossProfit	6586000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	5370000	usd
CY2021	us-gaap	Other Expenses OtherExpenses	699000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	517000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-105000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	412000	usd
CY2021	us-gaap	Other Income Tax Expense Benefit Continuing Operations OtherIncomeTaxExpenseBenefitContinuingOperations	-39000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	451000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	44179000	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	3268000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	41511000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	3270000	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	33634000	usd
CY2021Q4	us-gaap	Noncurrent Assets NoncurrentAssets	1097000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1026000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	235000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	759000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	276000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	209000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	152000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	92000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	79000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	412000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1220000	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	355000	usd
CY2023	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	500000000	ils
CY2023	us-gaap	Payments For Advance To Affiliate PaymentsForAdvanceToAffiliate	138000000	usd
CY2023	dei	Entity Registrant Name EntityRegistrantName	BOS BETTER ONLINE SOLUTIONS LTD
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	L3
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021	us-gaap	Other Income OtherIncome		usd
CY2023	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues		usd
CY2023	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities		usd
CY2021	us-gaap	Payments To Acquire Assets Investing Activities PaymentsToAcquireAssetsInvestingActivities		usd
CY2022	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets		usd
CY2021	us-gaap	Payments To Acquire Other Productive Assets PaymentsToAcquireOtherProductiveAssets		usd
CY2023	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2021Q4	us-gaap	Goodwill Goodwill	4676000	usd
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2022Q4	us-gaap	Goodwill Goodwill	4895000	usd
CY2023	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod		usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss		usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet		usd
CY2023	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit		usd
CY2022	us-gaap	Other Tax Expense Benefit OtherTaxExpenseBenefit		usd
CY2023	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations		usd
CY2022	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations		usd
CY2023	bosc	Expenses Regarding Warrants Granted Underlying Loan Agreement With Ya ExpensesRegardingWarrantsGrantedUnderlyingLoanAgreementWithYA		usd
CY2022	bosc	Expenses Regarding Warrants Granted Underlying Loan Agreement With Ya ExpensesRegardingWarrantsGrantedUnderlyingLoanAgreementWithYA		usd
CY2021	bosc	Expenses Regarding Warrants Granted Underlying Loan Agreement With Ya ExpensesRegardingWarrantsGrantedUnderlyingLoanAgreementWithYA		usd
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001005516

Files In Submission

Name	View Source	Status
0001213900-24-028176-index-headers.html	Edgar Link	pending
0001213900-24-028176-index.html	Edgar Link	pending
0001213900-24-028176.txt	Edgar Link	pending
0001213900-24-028176-xbrl.zip	Edgar Link	pending
bosc-20231231.xsd	Edgar Link	pending
ea0202881-20f_bosbetter.htm	Edgar Link	pending
ea020288101ex12-1_bosbetter.htm	Edgar Link	pending
ea020288101ex12-2_bosbetter.htm	Edgar Link	pending
ea020288101ex13-1_bosbetter.htm	Edgar Link	pending
ea020288101ex23-1_bosbetter.htm	Edgar Link	pending
ea020288101ex4-2_bosbetter.htm	Edgar Link	pending
ea020288101ex97-1_bosbetter.htm	Edgar Link	pending
ex23-1_001.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img_001.jpg	Edgar Link	pending
img_002.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
bosc-20231231_cal.xml	Edgar Link	unprocessable
ea0202881-20f_bosbetter_htm.xml	Edgar Link	completed
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
bosc-20231231_lab.xml	Edgar Link	unprocessable
bosc-20231231_def.xml	Edgar Link	unprocessable
bosc-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BOSC
BOS BETTER ONLINE SOLUTIONS LTD Stock $bosc

2024 Q1 Form 20-F Financial Statement

#000121390024028176 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BOSC BOS BETTER ONLINE SOLUTIONS LTD Stock $bosc

2024 Q1 Form 20-F Financial Statement

#000121390024028176 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BOSC
BOS BETTER ONLINE SOLUTIONS LTD Stock $bosc